Mediplantex National Pharmaceutical JSC

52
Hold
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000MED5
VND
20,400.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Mediplantex National Pharmaceutical JSC Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
19,949.00
19,418.00
14,923.00
8,236.00
5,369.00
30,984.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-40,030.00
22,772.00
-56,104.00
-20,937.00
53,208.00
61,444.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-14,771.00
48,773.00
-36,703.00
-4,265.00
65,477.00
92,729.00
Cash Flow from Investing Activities
418.00
-1,979.00
31,849.00
-127,268.00
-47,354.00
-58,219.00
Cash Flow from Financing Activities
-3,857.00
-47,697.00
-32,798.00
166,456.00
-25,220.00
-24,302.00
Net Cash Inflow / Outflow
-18,209.00
-922.00
-37,649.00
34,982.00
-6,982.00
10,219.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
-19.00
2.00
60.00
115.00
10.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in VND Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Mediplantex National Pharmaceutical JSC
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
Profit Before Tax
19949.786313
137125.966162
-1,17,176.00
-85.45%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-40030.116785
-88697.455781
48,667.00
54.87%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-14771.206439
32870.496221
-47,641.00
-144.94%
Cash Flow from Investing Activities
418.923073
-55632.142273
56,050.00
100.75%
Cash Flow from Financing Activities
-3857.620652
-95943.306
92,086.00
95.98%
Net Cash Inflow / Outflow
-18209.904018
-118679.648802
1,00,470.00
84.66%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
25.30325
-25.00
-100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is -130.29% vs 232.88% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-14,771.21
48,773.54
-130.29%